Denis Roy

Gründer bei SpecificiT Pharma, Inc.

Commercial Services

Profil

Denis Roy is the founder of SpecificiT Pharma, Inc. and Centre For Commercialization of Cancer Immunotherapy.
At SpecificiT Pharma, Inc., he holds no specific title.
At Centre For Commercialization of Cancer Immunotherapy, he held the title of Director, but it was previously inactive.

Aktive Positionen von Denis Roy

Unternehmen	Position	Beginn
SpecificiT Pharma, Inc. SpecificiT Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services SpecificiT Pharma, Inc. develops personalized cancer immunotherapies. The company is headquartered in Westmount, Canada.	Gründer	-
Centre For Commercialization of Cancer Immunotherapy Centre For Commercialization of Cancer Immunotherapy Centre For Commercialization of Cancer Immunotherapy provides solution for the development, translation, and commercialization of cancer immunotherapy and regenerative medicine. It offers clinical research unit, contract research organization, and innovation and commercialization unit services. The company was founded by Lambert Busque, Denis-Claude Roy and is headquartered in Montréal, Canada.	Gründer	-

Alle aktiven Positionen von Denis Roy

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Denis Roy im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	2
SpecificiT Pharma, Inc. SpecificiT Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services SpecificiT Pharma, Inc. develops personalized cancer immunotherapies. The company is headquartered in Westmount, Canada.	Commercial Services
Centre For Commercialization of Cancer Immunotherapy Centre For Commercialization of Cancer Immunotherapy Centre For Commercialization of Cancer Immunotherapy provides solution for the development, translation, and commercialization of cancer immunotherapy and regenerative medicine. It offers clinical research unit, contract research organization, and innovation and commercialization unit services. The company was founded by Lambert Busque, Denis-Claude Roy and is headquartered in Montréal, Canada.